These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. A small deletion in the Duchenne/Becker muscular dystrophy locus--a functionally important region? Hart KA; Monaco AP; Kunkel LM; Bobrow M Hum Genet; 1987 Sep; 77(1):88-91. PubMed ID: 3040577 [TBL] [Abstract][Full Text] [Related]
43. Becker and Duchenne muscular dystrophy: a comparative morphological study. Dennett X; Shield LK; Clingan LJ; Woolley DA Aust Paediatr J; 1988; 24 Suppl 1():15-20. PubMed ID: 3202735 [TBL] [Abstract][Full Text] [Related]
44. [Molecular pathology of Duchenne and Becker muscular dystrophy]. Gilgenkrantz H; Chelly J; Récan D; Chafey P; Kaplan JC C R Seances Soc Biol Fil; 1992; 186(4):349-53. PubMed ID: 1301222 [TBL] [Abstract][Full Text] [Related]
45. [Differential diagnosis of Becker and Duchenne muscular dystrophy]. Alvarez Leal M; Hernández Sifuentes PM; Pérez-Zuno JA Gac Med Mex; 1994; 130(6):454-8. PubMed ID: 7557060 [TBL] [Abstract][Full Text] [Related]
46. Genomics and cure: understanding narratives of patients with Duchenne muscular dystrophy in Japan. Kato M Anthropol Med; 2018 Apr; 25(1):85-101. PubMed ID: 29533090 [TBL] [Abstract][Full Text] [Related]
47. Genetic epidemiology of Duchenne and Becker muscular dystrophy in Slovenia. Peterlin B; Zidar J; Meznaric-Petrusa M; Zupancic N Clin Genet; 1997 Feb; 51(2):94-7. PubMed ID: 9111995 [TBL] [Abstract][Full Text] [Related]
48. Stakeholder cooperation to overcome challenges in orphan medicine development: the example of Duchenne muscular dystrophy. Straub V; Balabanov P; Bushby K; Ensini M; Goemans N; De Luca A; Pereda A; Hemmings R; Campion G; Kaye E; Arechavala-Gomeza V; Goyenvalle A; Niks E; Veldhuizen O; Furlong P; Stoyanova-Beninska V; Wood MJ; Johnson A; Mercuri E; Muntoni F; Sepodes B; Haas M; Vroom E; Aartsma-Rus A Lancet Neurol; 2016 Jul; 15(8):882-890. PubMed ID: 27302365 [TBL] [Abstract][Full Text] [Related]
49. Differences in Investigator-Initiated Trials between Japan and Other Countries: Analyses of Clinical Trials Sponsored by Academia and Government in the ClinicalTrials.gov Registry and in the Three Japanese Registries. Ito T PLoS One; 2016; 11(2):e0148455. PubMed ID: 26848574 [TBL] [Abstract][Full Text] [Related]
51. Further studies of gene deletions that cause Duchenne and Becker muscular dystrophies. Forrest SM; Cross GS; Flint T; Speer A; Robson KJ; Davies KE Genomics; 1988 Feb; 2(2):109-14. PubMed ID: 3410474 [TBL] [Abstract][Full Text] [Related]
52. Correlation of clinical and deletion data in Duchenne and Becker muscular dystrophy. Hodgson S; Hart K; Abbs S; Heckmatt J; Rodillo E; Bobrow M; Dubowitz V J Med Genet; 1989 Nov; 26(11):682-93. PubMed ID: 2585468 [TBL] [Abstract][Full Text] [Related]
53. DNA deletions in mild and severe Becker muscular dystrophy. Hart KA; Hodgson S; Walker A; Cole CG; Johnson L; Dubowitz V; Bobrow M Hum Genet; 1987 Mar; 75(3):281-5. PubMed ID: 3030926 [TBL] [Abstract][Full Text] [Related]
54. Signs and symptoms of Duchenne muscular dystrophy and Becker muscular dystrophy among carriers in The Netherlands: a cohort study. Hoogerwaard EM; Bakker E; Ippel PF; Oosterwijk JC; Majoor-Krakauer DF; Leschot NJ; Van Essen AJ; Brunner HG; van der Wouw PA; Wilde AA; de Visser M Lancet; 1999 Jun; 353(9170):2116-9. PubMed ID: 10382696 [TBL] [Abstract][Full Text] [Related]
55. [Patient database and orphan drug development]. Mizushima H; Tanabe M; Kanatani Y Yakugaku Zasshi; 2014; 134(5):599-605. PubMed ID: 24790040 [TBL] [Abstract][Full Text] [Related]
56. Segregation analysis of a marker localised Xp21.2-Xp21.3 in Duchenne and Becker muscular dystrophy families. Dorkins H; Junien C; Mandel JL; Wrogemann K; Moison JP; Martinez M; Old JM; Bundey S; Schwartz M; Carpenter N Hum Genet; 1985; 71(2):103-7. PubMed ID: 2995231 [TBL] [Abstract][Full Text] [Related]
57. The value of a European registry for pituitary adenomas: the example of Cushing's syndrome registry. Webb SM; Santos A; Valassi E Ann Endocrinol (Paris); 2012 Apr; 73(2):83-9. PubMed ID: 22541996 [TBL] [Abstract][Full Text] [Related]
58. Analysis of dystrophin gene in Iranian Duchenne and Becker muscular dystrophies patients and identification of a novel mutation. Zamani GR; Karami F; Mehdizadeh M; Movafagh A; Nilipour Y; Zamani M Neurol Sci; 2015 Nov; 36(11):2011-7. PubMed ID: 26081009 [TBL] [Abstract][Full Text] [Related]
59. Duchenne and Becker muscular dystrophy prevalence in South Africa and molecular findings in 128 persons affected. Ballo R; Viljoen D; Beighton P S Afr Med J; 1994 Aug; 84(8 Pt 1):494-7. PubMed ID: 7825085 [TBL] [Abstract][Full Text] [Related]
60. Identification of carriers of Duchenne/Becker muscular dystrophy by a novel method based on detection of junction fragments in the dystrophin gene. Yamagishi H; Kato S; Hiraishi Y; Ishihara T; Hata J; Matsuo N; Takano T J Med Genet; 1996 Dec; 33(12):1027-31. PubMed ID: 9004137 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]